Myriad Genetics (Association for Molecular Pathology v)
569 US 576 (2013)
JurisdictionUnited States
Year2013
Statusunclear
Key Principle
Naturally occurring DNA segments are products of nature and are not patent-eligible under 35 USC §101; synthetically created complementary DNA (cDNA) is patent-eligible.